Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Potentials and challenges of chip technologies in serum biomarker studies for personalized medicine of colorectal cancer
Stefanie Bünger
*
,
Timo Gemoll
, Jens K. Habermann
*
Corresponding author for this work
Clinic of Surgery
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Potentials and challenges of chip technologies in serum biomarker studies for personalized medicine of colorectal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Biological Marker
100%
Biomarker Study
100%
Cancer Staging
25%
Colorectal Carcinoma
100%
Early Cancer Detection
25%
Health Care Cost
25%
Protein Expression
25%
Proteome
25%
Reproducibility
25%
Screening
25%
Survival Rate
25%
Translational Research
25%
Biochemistry, Genetics and Molecular Biology
Biomarker Study
100%
Cancer Staging
50%
Colon
50%
Molecular Network
50%
Protein Expression
50%
Proteome
50%
Screening
50%
Survival Rate
50%
Immunology and Microbiology
Cancer Staging
100%
Colon
100%
Survival Rate
100%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Cancer Staging
25%
Colorectal Carcinoma
100%
Proteome
25%
Survival Rate
25%
Neuroscience
Protein Expression
100%
Proteome
100%